Global Antimalarial Medication market is expected to grow from US$ 1488 million in 2025 to US$ 1942 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.

Global Antimalarial Medication Market Size and Outlook 2025-31

The global Antimalarial Medication market size is predicted to grow from US$ 1488 million in 2025 to US$ 1942 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Antimalarial Medication Industry Forecast looks at past sales and reviews total world Antimalarial Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Antimalarial Medication sales for 2025 through 2031. With Antimalarial Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimalarial Medication industry. This Insight Report provides a comprehensive analysis of the global Antimalarial Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimalarial Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Antimalarial Medication market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimalarial Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimalarial Medication. This report presents a comprehensive overview, market shares, and growth opportunities of Antimalarial Medication market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Plasmodium Falciparum &nbsp;&nbsp;&nbsp; Plasmodium Malariae &nbsp;&nbsp;&nbsp; Plasmodium Vivax &nbsp;&nbsp;&nbsp; Plasmodium Ovale Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital Pharmacy &nbsp;&nbsp;&nbsp; Retail Pharmacy &nbsp;&nbsp;&nbsp; E- Commerce &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Sun Pharmaceutical Industries &nbsp;&nbsp;&nbsp; Merck Key Questions Addressed in this Report What is the 10-year outlook for the global Antimalarial Medication market? What factors are driving Antimalarial Medication market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Antimalarial Medication market opportunities vary by end market size? How does Antimalarial Medication break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Antimalarial Medication Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Antimalarial Medication by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Antimalarial Medication by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Antimalarial Medication Segment by Type &nbsp;2.2.1 Plasmodium Falciparum &nbsp;2.2.2 Plasmodium Malariae &nbsp;2.2.3 Plasmodium Vivax &nbsp;2.2.4 Plasmodium Ovale &nbsp;2.3 Antimalarial Medication Sales by Type &nbsp;2.3.1 Global Antimalarial Medication Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Antimalarial Medication Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Antimalarial Medication Sale Price by Type (2020-2025) &nbsp;2.4 Antimalarial Medication Segment by Application &nbsp;2.4.1 Hospital Pharmacy &nbsp;2.4.2 Retail Pharmacy &nbsp;2.4.3 E- Commerce &nbsp;2.4.4 Others &nbsp;2.5 Antimalarial Medication Sales by Application &nbsp;2.5.1 Global Antimalarial Medication Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Antimalarial Medication Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Antimalarial Medication Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Antimalarial Medication Breakdown Data by Company &nbsp;3.1.1 Global Antimalarial Medication Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Antimalarial Medication Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Antimalarial Medication Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Antimalarial Medication Revenue by Company (2020-2025) &nbsp;3.2.2 Global Antimalarial Medication Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Antimalarial Medication Sale Price by Company &nbsp;3.4 Key Manufacturers Antimalarial Medication Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Antimalarial Medication Product Location Distribution &nbsp;3.4.2 Players Antimalarial Medication Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Antimalarial Medication by Geographic Region &nbsp;4.1 World Historic Antimalarial Medication Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Antimalarial Medication Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Antimalarial Medication Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Antimalarial Medication Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Antimalarial Medication Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Antimalarial Medication Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Antimalarial Medication Sales Growth &nbsp;4.4 APAC Antimalarial Medication Sales Growth &nbsp;4.5 Europe Antimalarial Medication Sales Growth &nbsp;4.6 Middle East & Africa Antimalarial Medication Sales Growth 5 Americas &nbsp;5.1 Americas Antimalarial Medication Sales by Country &nbsp;5.1.1 Americas Antimalarial Medication Sales by Country (2020-2025) &nbsp;5.1.2 Americas Antimalarial Medication Revenue by Country (2020-2025) &nbsp;5.2 Americas Antimalarial Medication Sales by Type (2020-2025) &nbsp;5.3 Americas Antimalarial Medication Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Antimalarial Medication Sales by Region &nbsp;6.1.1 APAC Antimalarial Medication Sales by Region (2020-2025) &nbsp;6.1.2 APAC Antimalarial Medication Revenue by Region (2020-2025) &nbsp;6.2 APAC Antimalarial Medication Sales by Type (2020-2025) &nbsp;6.3 APAC Antimalarial Medication Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Antimalarial Medication by Country &nbsp;7.1.1 Europe Antimalarial Medication Sales by Country (2020-2025) &nbsp;7.1.2 Europe Antimalarial Medication Revenue by Country (2020-2025) &nbsp;7.2 Europe Antimalarial Medication Sales by Type (2020-2025) &nbsp;7.3 Europe Antimalarial Medication Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Antimalarial Medication by Country &nbsp;8.1.1 Middle East & Africa Antimalarial Medication Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Antimalarial Medication Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Antimalarial Medication Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Antimalarial Medication Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Antimalarial Medication &nbsp;10.3 Manufacturing Process Analysis of Antimalarial Medication &nbsp;10.4 Industry Chain Structure of Antimalarial Medication 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Antimalarial Medication Distributors &nbsp;11.3 Antimalarial Medication Customer 12 World Forecast Review for Antimalarial Medication by Geographic Region &nbsp;12.1 Global Antimalarial Medication Market Size Forecast by Region &nbsp;12.1.1 Global Antimalarial Medication Forecast by Region (2026-2031) &nbsp;12.1.2 Global Antimalarial Medication Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Antimalarial Medication Forecast by Type (2026-2031) &nbsp;12.7 Global Antimalarial Medication Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 GlaxoSmithKline &nbsp;13.1.1 GlaxoSmithKline Company Information &nbsp;13.1.2 GlaxoSmithKline Antimalarial Medication Product Portfolios and Specifications &nbsp;13.1.3 GlaxoSmithKline Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 GlaxoSmithKline Main Business Overview &nbsp;13.1.5 GlaxoSmithKline Latest Developments &nbsp;13.2 F. Hoffmann-La Roche &nbsp;13.2.1 F. Hoffmann-La Roche Company Information &nbsp;13.2.2 F. Hoffmann-La Roche Antimalarial Medication Product Portfolios and Specifications &nbsp;13.2.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 F. Hoffmann-La Roche Main Business Overview &nbsp;13.2.5 F. Hoffmann-La Roche Latest Developments &nbsp;13.3 Novartis &nbsp;13.3.1 Novartis Company Information &nbsp;13.3.2 Novartis Antimalarial Medication Product Portfolios and Specifications &nbsp;13.3.3 Novartis Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Novartis Main Business Overview &nbsp;13.3.5 Novartis Latest Developments &nbsp;13.4 Pfizer &nbsp;13.4.1 Pfizer Company Information &nbsp;13.4.2 Pfizer Antimalarial Medication Product Portfolios and Specifications &nbsp;13.4.3 Pfizer Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Pfizer Main Business Overview &nbsp;13.4.5 Pfizer Latest Developments &nbsp;13.5 Sun Pharmaceutical Industries &nbsp;13.5.1 Sun Pharmaceutical Industries Company Information &nbsp;13.5.2 Sun Pharmaceutical Industries Antimalarial Medication Product Portfolios and Specifications &nbsp;13.5.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Sun Pharmaceutical Industries Main Business Overview &nbsp;13.5.5 Sun Pharmaceutical Industries Latest Developments &nbsp;13.6 Merck &nbsp;13.6.1 Merck Company Information &nbsp;13.6.2 Merck Antimalarial Medication Product Portfolios and Specifications &nbsp;13.6.3 Merck Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Merck Main Business Overview &nbsp;13.6.5 Merck Latest Developments 14 Research Findings and Conclusion

Report	Global Antimalarial Medication Market Growth 2025-2031
Selected License	Multi ID: LPI24331

Buyer Information

Order Summary